Article
CD133 Is Essential for Glioblastoma Stem Cell Maintenance
11 Jan 2013
Abstract excerpt
The role of the cell surface CD133 as a cancer stem cell marker in glioblastoma (GBM) has been widely investigated, since it identifies cells that are able to initiate neurosphere growth and form heterogeneous tumors when transplanted in immune-compromised mice. However, evidences of CD133-negative cells exhibiting similar properties have also been reported. Moreover, the functional role of CD133 in cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
